Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Capital Expenditures (2021 - 2025)

Invivyd's (IVVD) quarterly Capital Expenditures came in at $11000.0 in Q2 2025, up 114.47% on a YoY basis from $5128.8 in Q2 2024, and down 92.36% quarter-over-quarter from $144000.0 in Q1 2025.

Analysis

Invivyd (IVVD) Capital Expenditures (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Capital Expenditures for 5 consecutive years, with $11000.0 the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Capital Expenditures rose 114.47% year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $155000.0 (up 209.93% YoY), and the FY2025 full-year result was $155000.0, up 209.93% from the prior year.
  • Capital Expenditures slipped to $11000.0 in Q2 2025 per IVVD's latest filing, from $144000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $6.0 million in Q3 2021 and bottomed at -$7.4 million in Q4 2024.
  • Historically, Capital Expenditures has averaged $58571.4 across 5 years, with a median of $1000.0 in 2023.
  • The widest YoY moves for Capital Expenditures: up 169.55% in 2024, down 744.44% in 2024.
  • Over 5 years, Capital Expenditures stood at -$2.7 million in 2021, then surged by 98.34% to -$45000.0 in 2022, then surged by 80.0% to -$9000.0 in 2023, then slumped by 82322.22% to -$7.4 million in 2024, then soared by 100.15% to $11000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $11000.0, $144000.0, and -$7.4 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 34.68 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 40.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.26 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 11,000.00
Mar 31, 2025 144,000.00
Dec 31, 2024 -7.42 Mn
Sep 30, 2024 5.67 Mn
Jun 30, 2024 -76,000.00
Mar 31, 2024 1.68 Mn
Jun 30, 2023 -9,000.00
Mar 31, 2023 624,000.00
Dec 31, 2022 -45,000.00
Sep 30, 2022 -63,000.00
Jun 30, 2022 62,000.00
Mar 31, 2022 -3.06 Mn
Dec 31, 2021 -2.72 Mn
Sep 30, 2021 6.02 Mn